[1]
Bellone, M. et al. 2018. Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation. Farmeconomia. Health economics and therapeutic pathways. 19, 1 (Feb. 2018). DOI:https://doi.org/10.7175/fe.v19i1.1346.